Main > DERMATOLOGY > USA. A. AD>Treat.>JAK Inhibitor Tab

---

USA. A. AD>Treat.>JAK Inhibitor Tab's subsections
(*) EU CE Mark Date: 2021. 08.24.
(*) USA Approval Date: 2022. 01.14
Company
Generic Name: upadacitinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 16
Patent>UpDate: 2022. 01.11
RTM
RTM Web-Site

USA. A. AD>Treat.>JAK Inhibitor Tab's products
This section has no products